5 Under-the-Radar Tickers That Will Stomp the Market in 2021
In 2020, coronavirus vaccine stocks have been amazing investments, particularly the small biotechs. Novavax (NASDAQ: NVAX), for example, is up over 2,000%. I actually bought shares in January, so I've been riding that wave all year. My family added to our position last week at $85 a share, so I'm bullish on Novavax, even at these prices. Of course, it was extremely profitable to buy at $4 a share, when the market hated it.
While buying unloved stocks is definitely risky, the rewards can be great. Here are five cold stocks that are good candidates to heat up in 2021.
Image source: Getty Images.
Source Fool.com
